The success of pathogens depends on their ability to circumvent immune defences. Francisella tularensis is one of the most infectious bacteria known. The remarkable virulence of Francisella is believed to be due to its capacity to evade or subvert the immune system, but how remains obscure. Here, we show that Francisella triggers but concomitantly inhibits the Toll-like receptor, RIG-I-like receptor, and cytoplasmic DNA pathways. Francisella subverts these pathways at least in part by inhibiting K63-linked polyubiquitination and assembly of TRAF6 and TRAF3 complexes that control the transcriptional responses of pattern recognition receptors. We show that this mode of inhibition requires a functional type VI secretion system and/or the presence of live bacteria in the cytoplasm. The ability of Francisella to enter the cytosol while simultaneously inhibiting multiple pattern recognition receptor pathways may account for the notable capacity of this bacterium to invade and proliferate in the host without evoking a self-limiting innate immune response.
| INTRODUCTION
The success of pathogens depends on their ability to elude the immune system. Francisella tularensis, the etiological agent of the debilitating illness tularaemia, is one of the most infectious bacteria known and is among the top six potential bioterrorism agents, so-called Category A agents (Darling, Catlett, Huebner, & Jarrett, 2002) . The remarkable virulence of Francisella is believed to be due to its capacity to invade and proliferate in the host without evoking a self-limiting immune reaction (Bosio, 2011; Pechous, McCarthy, & Zahrt, 2009; Steiner, Furuya, & Metzger, 2014) .
The innate immune detection of and responsiveness to microbes is mediated by pattern recognition receptors (PRRs) that recognise conserved microbe-associated molecular patterns (MAMPs) . PRRs include the cell surface or endosomal membrane-localised Toll-like receptors (TLRs) and the cytoplasmic PRRs such as RIG-I-like receptors (RLRs) and cytosolic DNA receptors (CDRs). Triggering of PRRs culminates in the transcriptional induction of proinflammatory cytokines and type I interferons (IFNs) that together coordinate antimicrobial immune defences (Kumar, Kawai, and Akira, 2011) .
In order to overcome the host barrier to infection, Francisella has been shown to employ several mechanisms to evade detection by the innate immune system. For example, Francisella expresses lipopolysaccharide (LPS) with an atypical structure poorly recognised by TLR4 (Ancuta, Pedron, Girard, Sandstrom, & Chaby, 1996; Huang et al., 2010; Phillips, Schilling, McLendon, Apicella, & Gibson, 2004) . Recently, Francisella has been demonstrated to evadeTLR2-mediated inflammatory responses by repressing the production of the TLR2 agonist lipoprotein (Jones, Sampson, Nakaya, Pulendran, & Weiss, 2012; Okan et al., 2013; Sampson, Saroj, Llewellyn, Tzeng, & Weiss, 2013) . Moreover, in the cytoplasm, Francisella has been suggested to limit the accessibility of microbeassociated molecular patterns to cytosolic PRRs, which may explain the propensity of cytotoxic bacterial mutants to elicit a higher innate immune response (Peng, Broz, Jones, Joubert, & Monack, 2011) .
In addition to these avoidance strategies, the ability of Francisella to colonise the host without stirring a strong inflammatory response is in part due to subversion of innate immune pathways. Active inhibition of innate immune signalling events including activation of the † These authors contributed equally to this work. nuclear factor kappa B, signal transducers of transcription factor 1, IFN regulatory factors 1 and 8 (IRF1 and IRF8), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase/Akt pathways has been reported (Cremer, Butchar, & Tridandapani, 2011; Ireland, Wang, Alinger, Small, & Bosio, 2013; Roth, Gunn, Lafuse, & Satoskar, 2009; Telepnev, Golovliov, Grundstrom, Tarnvik, & Sjostedt, 2003; Telepnev, Golovliov, & Sjostedt, 2005) . In spite of these insights, which PRR pathways are activated or inhibited upon Francisella infection and how remain poorly understood.
Ubiquitination is a critical posttranslational modification that regulates diverse cellular processes, including inflammatory responses.
Ubiquitination involves the conjugation of a single or multiple ubiquitins by ubiquitin ligases onto proteins, that is, monoubiquitination and polyubiquitination, respectively. During polyubiquitination, ubiquitins can be attached onto each other either via the N terminal methionine or any of its seven internal lysine residues (K6, K11, K27, K29, K33, K48, and K63). This results in polyubiquitin chains of diverse structures that control the signalling activity or stability of proteins. The best characterised are the K63-linked polyubiquitin chains that control signal complex formation and the K48-linked chains that target proteins for proteasomal degradation (Kulathu & Komander, 2012) .
Many pathogens well adapted to their host are known to activate PRR signalling cascades and subsequently suppress them. In fact, increasing evidence indicate that many pathogens do hijack the host ubiquitin system to their advantage (Ashida, Kim, & Sasakawa, 2014) .
Here, we show that F. tularensis live vaccine strain (LVS) triggers but concomitantly blocks the TLR, RLR, and CDR pathways. The E3 ligases TRAF6 and TRAF3 complexes are critical points of regulation for PRR pathways (Hacker et al., 2006; Panda, Nilsson, & Gekara, 2015) . Our data show that LVS inhibits K63-linked polyubiquitination and assembly of TRAF6 and TRAF3 signalling complexes. Analysis of LVS mutants suggests a role for the Francisella type VI secretion system (T6SS) and/or cytoplasmic localization of bacteria in such inhibition.
The ability of Francisella to inactivate these key proximal PRR complexes may account for the ability of this bacterium to inhibit multiple PRR pathways simultaneously and hence infect host cells without eliciting strong innate immune responses.
| RESULTS

| LVS weakly induces inflammatory responses via TLR, RLR, and CDR pathways
Francisella has a complicated life cycle involving transition from the cell surface to the endosomal compartment and finally into the cytosol.
Therefore, in theory, Francisella should be sensed by multiple PRR families. TLRs, RLRs, and CDRs are the major PRR pathways for transcriptional induction of innate immune mediators. How Francisella activates or manipulates these PRR pathways is not well understood. Type I IFNs play a key role in innate immune defences against Francisella (Henry, Brotcke, Weiss, Thompson, & Monack, 2007 (Figures 1 and S1A ,B). Notably, for Sting −/− cells, reduced IFN-β response was mainly at late time points (8-12 hr postinfection), whereas at earlier time points, elevated IFN-β response was observed in such cells (Figure 1c ). The enhanced response is probably due to a role for STING in negative regulation of TLRs (Sharma et al., 2015) . In brief, these findings illustrated that inflammatory response to Francisella involves a coordinated activation of TLR, RLR, and CDR pathways. This is consistent with previous observations (Cole et al., 2008 (Abdullah et al., 2012; Sauer et al., 2011; Witte et al., 2012) . LVSinduced innate immune responses were found to be very modest; at 2.2 | LVS blocks the TLR, RLR, and CDR pathways VSV-AV2 is a natural VSV strain with a mutation in the M protein and hence can mount a strong innate immune response mainly via the activation of the RLR pathway (Kato et al., 2006; Stojdl et al., 2003) . To further test the inhibitory effects of LVS on the RLR pathway, Ifnβ
Δβ-luc BMDMs preinfected with LVS were stimulated with VSV-AV2.
LVS severely blocked VSV-AV2-induced IFN-β luciferase response.
This was in clear contrast to L. monocytogenes that promoted VSV-AV2-induced responses ( Figure 3g ). Together, these findings demonstrate that during infection, LVS actively inhibits the TLR, RLR, and CDR pathways and that this phenomenon may account for the restrained innate immune response elicited by LVS. 
| LVS blocks proximal polyubiquitination and phosphorylation events in PRR pathways
Next, we sought to elucidate the signalling steps affected in Francisella- subsequently downregulates intracellular signalling (Telepnev et al., 2003; Telepnev et al., 2005) .
To more directly test Francisella-mediated inhibition of PRR pathways, these signalling events were also monitored under coin- (Figures 5b, S6D, and 6b) . In sum, these data demonstrate that LVS is an inhibitor of proximal PRR signalling events and its suppressive effects are largely dependent on a functional T6SS and/or entry of bacteria into the cytosol.
2.6 | LVS affects the polyubiquitination and assembly of TRAF6 and TRAF3 complexes IglC. These results demonstrate that LVS is an inhibitor of the TRAF6 and TRAF3 complex assembly and that this may account for its ability to simultaneously block multiple PRR pathways. whereas the STING-dependent responses could be due to the recognition of bacterial DNA in the cytoplasm by cGAS (Storek, Gertsvolf, Ohlson, & Monack, 2015) . The TRIF adaptor is traditionally known for its role in TLR3 and TLR4 signalling. However, TRIF is also essential for optimal activation of the TLR2-MYD88 (Petnicki-Ocwieja et al., 2013) and cGAS-STING (Wang et al., 2016) pathways. Similarly, in addition to its primary role in RNA-mediated activation RLRs, it is conceivable that IPS1 adaptor could potentiate the activation of cGAS-STING pathways via RNA polymerase III-dependent sensing of cytoplasmic DNA (Chiu, Macmillan, & Chen, 2009 ).
Although it remains unclear whether the TRIF-and IPS1-dependent inflammatory responses elicited by Francisella are due to the auxiliary role of these adaptors in the MYD88 and STING pathways, it is apparent that many PRR pathways are functionally interconnected and that the net inflammatory response upon Francisella infection is the product of a simultaneous or sequential activation of multiple PRR pathways. Thus, for a pathogen well adapted to its host, the most effective means to overcome the innate immune defences is a multipronged attack on diverse PRR pathways. The data herein show that although able to trigger the TLR, RLR, and CDR pathways, Francisella also actively blocks these pathways, and this could be due to its ability to target focal points of regulation for PRR pathways, the TRAF3 and TRAF6 complexes. In addition to these complexes, Francisella possibly also impedes other signalling steps, for example, upstream adaptors or receptors (Crane et al., 2013 ) or downstream at the transcription level (Bauler, Chase, Wehrly, & Bosio, 2014; Ireland et al., 2013; Walters et al., 2015) . Hence, in spite of the productive infection and high replication in macrophages, Francisella evokes only a weak innate immune response much to its advantage.
The specific bacterial effectors responsible for innate immune subversion are not clear. IglC and DsbA are essential for the T6SS (Qin et al., 2016) and are required for bacterial entry into the cytoplasm (Lindgren et al., 2004; Qin et al., 2009) , and Ips-1 −/− Ifnb+/Δβ-luc as recently described (Hartlova et al., 2015) .
| Antibodies and chemicals
Anti-IKKα/β, anti-p38 MAPK, anti-TAK1, anti-IRF3, anti-p-IRF3, and anti-K63-linkage specific-polyubiquitin antibody were from Cell Sig- lux/pHELP (Bron, Monk, Corr, Hill, & Gahan, 2006) , and GFP (Fortinea et al., 2000) strains were cultured in brain-heart infusion medium at 37°C in 5% CO 2 atmosphere. For infections, all bacterial strains were grown to exponential phase in a given bacterial medium corresponding to OD = 0.4 at 37°C. Francisella was inactivated by heating at 95°C for 10 min, by sonication (8× for 15 s at Grade 4) or by overnight ultraviolet inactivation. The efficiency of bacterial lysis was confirmed by lack of growth on McLeod's agar plate. Bacterial lysate was treated by 2.5 U/μl benzonase ® nuclease (Sigma-Aldrich) at 37°C for 45 min.
VSV-AV2 has been described before (Stojdl et al., 2003) .
| Preparation of BMDMs
To prepare BMDMs, bone marrow cells were isolated from mouse femurs and tibias and cultivated in Iscove's modified Dulbecco's medium (Life Technologies) supplemented with 10% fetal bovine serum (Thermo Fisher Scientific), 1% penicillin-streptomycin, and 20% (v/v) L929 cell-conditioned medium at 37°C in 5% CO 2 atmosphere for 5 days.
| Infection of bone marrow-derived macrophages
BMDMs seeded into 6-, 12-, 24-, or 96-well plates at a density of 
| Immunoblot analysis
Samples were separated by 10% SDS-PAGE and transferred onto Polyvinylidene difluoride (PVDF) or nitrocellulose membranes (GE Healthcare). Membranes were blocked for 1 hr with 1X RotiBlock (Roth) and subsequently incubated with different primary antibodies overnight. After incubation with HRP-labelled secondary antibodies, proteins were detected using Enhanced chemiluminescence (ECL) reagents and X-ray films. Immunoprecipitation and immunoblot analyses were performed as detailed in our recent study (Panda et al., 2015) . 
| Cell viability assay
Cell viability was tested by CytoTox-ONE Homogenous Membrane
Integrity Assay (Promega). Fluorescence was measured using TECAN Infinite M1000 PRO multimode microplate reader. Cell viability (%) was expressed as a percentage relative to the untreated control.
| Statistical analysis
The data are presented as mean with standard error of the mean (±SEM). Statistical analysis was performed using one-way analysis of variance with Bonferroni posttest or Mann-Whitney test using
GraphPad Prism 5 software.
